T
TotalFusionOne
I listen to the BBC a lot while I'm driving. Tonight's program (I think it was "The world today") was talking about the issues hospitals in India and the NHS is currently facing: Let up on drug rationing or make improvements to hospitals. I was trying to think of a way to make drugs cheaper for all (Since capitalism seems to be very anti current political climate), and I wanted to run something by the general public.
Currently in the US we have patent restrictions on FDA approved drugs. Once a drug is approved the formula is protected for a limited amount of time (I can't remember how long, but it's something along 7 or 17 years) before the formula is opened up and many drug companies can carbon copy. Now people always find a way around this by changing a thing here or there... But I have an odd solution to keep the cost of drugs low:
If a company agrees to cap the profit margin of a drug on the market at 10% - 15% above cost, the patent is extended an additional 10 years.
Now I'm opening this up for debate because I can't really see the downside, and I know there must be one. But what we'd have would be lower cost drugs with the drug companies seeing a reasonable, maybe better in some cases, return on their investment over time. Driving down the cost of medication would open it up for more people to be able to afford, improving the quality of life and still allowing profit margins for drug companies to keep researching new drugs. Everyone wins, except the competitors who have to try even harder to research the next big thing. Which ends up helping people more.
Thoughts?
Currently in the US we have patent restrictions on FDA approved drugs. Once a drug is approved the formula is protected for a limited amount of time (I can't remember how long, but it's something along 7 or 17 years) before the formula is opened up and many drug companies can carbon copy. Now people always find a way around this by changing a thing here or there... But I have an odd solution to keep the cost of drugs low:
If a company agrees to cap the profit margin of a drug on the market at 10% - 15% above cost, the patent is extended an additional 10 years.
Now I'm opening this up for debate because I can't really see the downside, and I know there must be one. But what we'd have would be lower cost drugs with the drug companies seeing a reasonable, maybe better in some cases, return on their investment over time. Driving down the cost of medication would open it up for more people to be able to afford, improving the quality of life and still allowing profit margins for drug companies to keep researching new drugs. Everyone wins, except the competitors who have to try even harder to research the next big thing. Which ends up helping people more.
Thoughts?